the g-doc

the g-doc

Explore health topics

Relationship Between Preoperative Endotoxin Immune Status, Gut Perfusion, and Outcome From Cardiac Valve Replacement Surgery - CHEST


Study objective

Endotoxin is a powerful trigger of systemic inflammation. Since cardiac surgery exposes patients to endotoxemia, this study was set up to define the relationship between preoperative endogenous endotoxin immune status, gut perfusion, and outcome following cardiac valve replacement surgery.

Design

Observational study.

Setting

University hospital.

Patients

Fifty-nine consecutive patients undergoing cardiac valve replacement.

Measurements and main results

Blood was assayed for IgG and IgM endotoxin core antibody (EndoCAb) levels preoperatively, immediately postoperatively, and at 4 h and 24 h postoperatively. Intraoperative gut mucosal perfusion was assessed using gastric tonometry. Complications were assessed for groups above and below the median EndoCAb value of a healthy population (100 median units μ/mL). Of the 59 patients, 12 developed at least one of a set of predefined complications. Of these 12, all had preoperative levels of IgM EndoCAb below 100 MU/mL (p<0.025). Eleven had IgG EndoCAb levels below 100 MU/mL (0.05

Conclusions

Preoperative EndoCAb levels were related to poor outcome following cardiac surgery and may be used to improve the specificity of GI tonometry in predicting postoperative complications.
To read this article in full you will need to make a payment

Purchase one-time access:

Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
  • For academic or personal research use, select 'Academic and Personal'
  • For corporate R&D use, select 'Corporate R&D Professionals'

Subscribe:

Subscribe to CHEST
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Institutional Access: Sign in to ScienceDirect

REFERENCES

  1. 1.
    • Machiedo G.W. •
    • Loverme P.J. •
    • McGovern P.J. •
    • et al.
    Patterns of mortality in a surgical intensive care unit.
    Surg Gynecol Obstet. 1981; 152: 757-759
  2. 1.
    • Wilson F.
    Surgical intensive care units.
    in: Parillo J.E. Ayres S.M. Major issues in critical care medicine. Williams & Wilkins, Baltimore1984: 17-33
  3. 1.
    • Luce J.M.
    Introduction of new technology into critical care practice: a history of Ha-IA human monoclonal antibody against endotoxin.
    Crit Care Med. 1993; 21: 1233-1241
  4. 1.
    • Kreger B.E. •
    • Craven D.E. •
    • Carling D.E. •
    • et al.
    Gram-negative bacteremia: III. Reassessment of etiology, epidemiology and ecology in 612 patients.
    Am J Med. 1980; 68: 332-344
  5. 1.
    • Coalson J.J.
    Pathophysiologic response of the subhuman primate in experimental shock.
    Lab Invest. 1975; 32: 561-569
  6. 1.
    • Tighe D. •
    • Moss R.F. •
    • Boghossian S. •
    • et al.
    Multi-organ damage resulting from faecal peritonitis.
    Clin Sci. 1989; 76: 269-276
  7. 1.
    • Danner R.L. •
    • Elin R.J. •
    • Hosseini J.M. •
    • et al.
    Endotoxemia in human septic shock.
    Chest. 1991; 99: 169-175
  8. 1.
    • Rush B.F. •
    • Sori A.J. •
    • Murphy T.F. •
    • et al.
    Endotoxemia and bacteremia during hemorrhagic shock: the link between trauma and sepsis?.
    Ann Surg. 1988; 207: 549-554
  9. 1.
    • Suffredini A.F. •
    • Fromm R.E. •
    • Parker M.M. •
    • et al.
    The cardiovascular response of normal humans to the administration of endotoxin.
    N Engl J Med. 1989; 321: 280-287
  10. 1.
    • Bjork J. •
    • Hugli T.E. •
    • Smedegard G.
    Microvascular effects of anaphylatoxins C3a and C5a.
    J Immunol. 1985; 134: 1115-1119
  11. 1.
    • Morrison D.C. •
    • Cochrane C.G.
    Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides.
    J Exp Med. 1974; 140: 797-802
  12. 1.
    • Andersen L.W. •
    • Baek L. •
    • Degn H.
    Presence of circulating endotoxin during cardiac operations.
    J Thorac Cardiovasc Surg. 1987; 93: 115-119
  13. 1.
    • Deitch E.A.
    The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure.
    Arch Surg. 1990; 125: 403-404
  14. 1.
    • Deitch E.A. •
    • Morrison J. •
    • Berg R. •
    • et al.
    Effect of hemorrhagic shock on bacterial translocation, intestinal morphology and intestinal permeability in conventional and antibiotic-decontaminated rats.
    Crit Care Med. 1990; 18: 529-536
  15. 1.
    • Fink M.P.
    Gastrointestinal mucosal injury in experimental models of shock, trauma, and sepsis.
    Crit Care Med. 1991; 19: 627-638
  16. 1.
    • Barclay G.R.
    Bacterial endotoxins: lipopolysaccharides from genes to therapy.
    in: Levin J. Alving C.R. Munford R.S. Progress in clinical and biological research. John Wiley & Sons, New York1995: 263-272
  17. 1.
    • Poxton I.R.
    Antibodies to lipopolysaccharide.
    J Immunol Methods. 1995; 186: 1-15
  18. 1.
    • Baumgartner J.D.
    Immunotherapy with antibodies to core lipopolysaccharide: a critical appraisal.
    Infect Dis Clin North Am. 1991; 5: 915-927
  19. 1.
    • Scott B.B. •
    • Barclay G.R.
    Endotoxin-polymyxin complexes in an improved enzyme-linked immunosorbent assay for IgG antibodies in blood donor sera to Gram-negative endotoxin core glycolipids.
    Vox Sang. 1987; 52: 272-280
  20. 1.
    • Derrington M.C. •
    • Smith G.
    A review of studies of anaesthetic risk, morbidity and mortality.
    Br J Anaesth. 1988; 59: 815-833
  21. 1.
    • Parsonnet V. •
    • Dean D. •
    • Bernstein A.D.
    A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease.
    Circulation. 1989; 79: 1.3-1.12
  22. 1.
    • Salmon J.B. •
    • Hamilton-Davies C. •
    • Webb A.R.
    Aspiration technique influences the results of gastric tonometry.
    Clin Intensive Care. 1995; 6: 203
  23. 1.
    • DeMaria A.J. •
    • Johns M.A. •
    • Berberich H. •
    • et al.
    Immunization with rough mutants of Salmonella minnesota: initial studies in human subjects.
    J Infect Dis. 1988; 158: 301-311
  24. 1.
    • Gould E.K. •
    • Harvey J.A. •
    • Dytrych J.K.
    Antibody to endotoxin is associated with decreased frequency of postoperative infection.
    Am J Obstet Gynecol. 1989; 160: 317-319
  25. 1.
    • McCloskey R.V. •
    • Straube R.C. •
    • Sanders C. •
    • et al.
    Treatment of septic shock with human monoclonal antibody.
    Ann Intern Med. 1994; 121: 1-5
  26. 1.
    • Bone R.C. •
    • Balk R.A. •
    • Fein A.M. •
    • et al.
    A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial.
    Crit Care Med. 1995; 23: 994-1006
  27. 1.
    • Goldie A.S. •
    • Fearon K.C. •
    • Ross J.A. •
    • et al.
    Natural cytokine antagonists and endogenous endotoxin antibodies in the sepsis syndrome.
    JAMA. 1995; 274: 172-177
  28. 1.
    • Hamilton-Davies C. •
    • Barclay G.R. •
    • Murphy W.G. •
    • et al.
    Passive immunisation with IgG endotoxin core antibody hyperimmune fresh frozen plasma.
    Vox Sang. 1996; 71: 165-169
  29. 1.
    • Riddington D.W. •
    • Venkatesh B. •
    • Boivin C.M. •
    • et al.
    Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass.
    JAMA. 1996; 275: 1007-1012
  30. 1.
    • Mythen M.G. •
    • Barclay G.R. •
    • Hamilton-Davies C. •
    • et al.
    The role of endotoxin immunity, neutrophil degranulation and contact activation in the pathogenesis of post-operative organ failure.
    Br J Anaesth. 1988; 4: 999-1005
  31. 1.
    • Nelson D.P. •
    • Samsel R.W. •
    • Wood L.D. •
    • et al.
    Pathological supply dependence of systemic and intestinal O2 uptake during endotoxemia.
    J Appl Physiol. 1988; 64: 2410-2419
  32. 1.
    • Bennett-Guerrerro E. •
    • Ayuso L. •
    • Hamilton-Davies C. •
    • et al.
    Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery.
    JAMA. 1997; 277: 646-650

Article info

Publication history

Accepted: May 17, 1997
Received: November 11, 1996

Copyright

© 1997 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Related Articles

Published by the g-doc on